Back

Genome-wide association study of REM sleep behavior disorder identifies novel loci with distinct polygenic and brain expression effects

Krohn, L.; Heilbron, K.; Blauwendraat, C.; Reynolds, R. H.; Yu, E.; Senkevich, K.; Rudakou, U.; Estiar, M. A.; Gustavsson, E.; Brolin, K.; Ruskey, J. A.; Freeman, K.; Asayesh, F.; Chia, R.; Arnulf, I.; Hu, M. T. M.; Montplaisir, J. Y.; Trempe, J.-F.; Desautels, A.; Dauvilliers, Y.; Gigli, G. L.; Valente, M.; Janes, F.; Bernardini, A.; Högl, B.; Stefani, A.; Ibrahim, A.; Sonka, K.; Kemlink, D.; Oertel, W.; Janzen, A.; Plazzi, G.; Antelmi, E.; Figorilli, M.; Puligheddu, M.; Mollenhauer, B.; Trenkwalder, C.; Sixel-Döring, F.; Cochen de Cock, V.; Monaca, C. C.; Heidbreder, A.; Ferini-Strambi, L.

2021-09-13 genetic and genomic medicine
10.1101/2021.09.08.21254232 medRxiv
Show abstract

Rapid eye movement (REM) sleep behavior disorder (RBD), enactment of dreams during REM sleep, is an early clinical symptom of alpha-synucleinopathies. RBD also defines more severe forms of alpha-synucleinopathies. The genetic background of RBD and its underlying mechanisms are not well understood. Here, we performed the first genome-wide association study of RBD, identifying five RBD risk loci. Expression analyses highlight SNCA-AS1 and SCARB2 differential expression in different brain regions in RBD, with SNCA-AS1 further supported by colocalization analyses. Genetic risk score and other analyses provide further insights into RBD genetics, highlighting RBD as a unique subpopulation that will allow future early intervention.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.